메뉴 건너뛰기




Volumn 14, Issue 9, 2015, Pages 1167-1179

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis

Author keywords

immunogenicity; Ixiaro; Japanese encephalitis; Japanese encephalitis vaccine; JE VC; safety; traveler

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; INACTIVATED VACCINE;

EID: 84939436228     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2015.1061939     Document Type: Article
Times cited : (27)

References (85)
  • 1
    • 84884391626 scopus 로고    scopus 로고
    • Japanese encephalitis: Status of surveillance and immunization in Asia and the Western Pacific, 2012
    • Japanese encephalitis: status of surveillance and immunization in Asia and the Western Pacific, 2012. Wkly Epidemiol Rec 2013; 88(34):357-64
    • (2013) Wkly Epidemiol Rec , vol.88 , Issue.34 , pp. 357-364
  • 2
    • 80053498530 scopus 로고    scopus 로고
    • Estimated global incidence of Japanese encephalitis: A systematic review
    • Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011;89(10):766-74
    • (2011) Bull World Health Organ , vol.89 , Issue.10 , pp. 766-774
    • Campbell, G.L.1    Hills, S.L.2    Fischer, M.3
  • 4
    • 0037372114 scopus 로고    scopus 로고
    • Origin and evolution of Japanese encephalitis virus in southeast Asia
    • Solomon T, Ni H, Beasley DW, et al. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 2003;77(5):3091-8
    • (2003) J Virol , vol.77 , Issue.5 , pp. 3091-3098
    • Solomon, T.1    Ni, H.2    Beasley, D.W.3
  • 5
    • 0034724247 scopus 로고    scopus 로고
    • Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus
    • Tsarev SA, Sanders ML, Vaughn DW, et al. Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine 2000;18(Suppl 2):36-43
    • (2000) Vaccine , vol.18 , pp. 36-43
    • Tsarev, S.A.1    Sanders, M.L.2    Vaughn, D.W.3
  • 6
    • 0036116402 scopus 로고    scopus 로고
    • Japanese encephalitis virus: Ecology and epidemiology
    • Endy TP, Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 2002;267:11-48
    • (2002) Curr Top Microbiol Immunol , vol.267 , pp. 11-48
    • Endy, T.P.1    Nisalak, A.2
  • 7
  • 8
    • 0035680905 scopus 로고    scopus 로고
    • The appearance of a second genotype of Japanese encephalitis virus in the Australasian region
    • Pyke AT, Williams DT, Nisbet DJ, et al. The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg 2001;65(6):747-53
    • (2001) Am J Trop Med Hyg , vol.65 , Issue.6 , pp. 747-753
    • Pyke, A.T.1    Williams, D.T.2    Nisbet, D.J.3
  • 9
    • 2942661866 scopus 로고    scopus 로고
    • Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: Implications for frequent introductions of JEV from southeast Asia to east Asia
    • Nga PT, del Carmen Parquet M, Cuong VD, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from southeast Asia to east Asia. J Gen Virol 2004;85(Pt 6):1625-31
    • (2004) J Gen Virol , vol.85 , pp. 1625-1631
    • Nga, P.T.1    Del Carmen-Parquet, M.2    Cuong, V.D.3
  • 10
    • 55549146124 scopus 로고    scopus 로고
    • Change in Japanese encephalitis virus distribution, Thailand
    • Nitatpattana N, Dubot-Peres A, Gouilh MA, et al. Change in Japanese encephalitis virus distribution, Thailand. Emerg Infect Dis 2008;14(11):1762-5
    • (2008) Emerg Infect Dis , vol.14 , Issue.11 , pp. 1762-1765
    • Nitatpattana, N.1    Dubot-Peres, A.2    Gouilh, M.A.3
  • 11
    • 77953355577 scopus 로고    scopus 로고
    • Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005
    • Yun SM, Cho JE, Ju YR, et al. Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005. Virol J 2010;7:127
    • (2010) Virol J , vol.7 , pp. 127
    • Yun, S.M.1    Cho, J.E.2    Ju, Y.R.3
  • 12
    • 84897012118 scopus 로고    scopus 로고
    • Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia
    • Schuh AJ, Ward MJ, Leigh Brown AJ, et al. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J Virol 2014;88(8):4522-32
    • (2014) J Virol , vol.88 , Issue.8 , pp. 4522-4532
    • Schuh, A.J.1    Ward, M.J.2    Leigh Brown, A.J.3
  • 13
    • 84920517170 scopus 로고    scopus 로고
    • Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005-2012
    • Su CL, Yang CF, Teng HJ, et al. Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005-2012. PLoS Negl Trop Dis 2014;8(10):e3122
    • (2014) PLoS Negl Trop Dis , vol.8 , Issue.10 , pp. e3122
    • Su, C.L.1    Yang, C.F.2    Teng, H.J.3
  • 14
    • 79960942589 scopus 로고    scopus 로고
    • Genotype v Japanese encephalitis virus is emerging
    • Li MH, Fu SH, Chen WX, et al. Genotype v Japanese encephalitis virus is emerging. PLoS Negl Trop Dis 2011;5(7):e1231
    • (2011) PLoS Negl Trop Dis , vol.5 , Issue.7 , pp. e1231
    • Li, M.H.1    Fu, S.H.2    Chen, W.X.3
  • 15
    • 80053173339 scopus 로고    scopus 로고
    • Emergence of Japanese encephalitis virus genotype v in the Republic of Korea
    • Takhampunya R, Kim HC, Tippayachai B, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J 2011;8:449
    • (2011) Virol J , vol.8 , pp. 449
    • Takhampunya, R.1    Kim, H.C.2    Tippayachai, B.3
  • 16
    • 84922511750 scopus 로고    scopus 로고
    • Detection of Japanese encephalitis virus genotype v in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea
    • Kim H, Cha GW, Jeong YE, et al. Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea. PLoS One 2015;10(2):e0116547
    • (2015) PLoS One , vol.10 , Issue.2 , pp. e0116547
    • Kim, H.1    Cha, G.W.2    Jeong, Y.E.3
  • 18
    • 0036103618 scopus 로고    scopus 로고
    • Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections
    • Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002;267:171-94
    • (2002) Curr Top Microbiol Immunol , vol.267 , pp. 171-194
    • Solomon, T.1    Vaughn, D.W.2
  • 19
    • 74549198630 scopus 로고    scopus 로고
    • Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
    • Hills S, Dabbagh A, Jacobson J, et al. Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance. BMC Infect Dis 2009;9:214
    • (2009) BMC Infect Dis , vol.9 , pp. 214
    • Hills, S.1    Dabbagh, A.2    Jacobson, J.3
  • 21
    • 49749089318 scopus 로고    scopus 로고
    • Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand
    • Lehtinen VA, Huhtamo E, Siikamaki H, et al. Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand. J Clin Virol 2008;43(1):93-5
    • (2008) J Clin Virol , vol.43 , Issue.1 , pp. 93-95
    • Lehtinen, V.A.1    Huhtamo, E.2    Siikamaki, H.3
  • 22
    • 65649083413 scopus 로고    scopus 로고
    • Japanese encephalitis in travelers: Review of cases and seasonal risk
    • Buhl MR, Lindquist L. Japanese encephalitis in travelers: review of cases and seasonal risk. J Travel Med 2009;16(3): 217-19
    • (2009) J Travel Med , vol.16 , Issue.3 , pp. 217-219
    • Buhl, M.R.1    Lindquist, L.2
  • 23
    • 65649121208 scopus 로고    scopus 로고
    • Japanese encephalitis: Defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland
    • Hatz C, Werlein J, Mutsch M, et al. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland. J Travel Med 2009;16(3):200-3
    • (2009) J Travel Med , vol.16 , Issue.3 , pp. 200-203
    • Hatz, C.1    Werlein, J.2    Mutsch, M.3
  • 24
    • 77952687751 scopus 로고    scopus 로고
    • Japanese encephalitis in travelers from non-endemic countries, 1973-2008
    • Hills SL, Griggs AC, Fischer M. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg 2010;82(5):930-6
    • (2010) Am J Trop Med Hyg , vol.82 , Issue.5 , pp. 930-936
    • Hills, S.L.1    Griggs, A.C.2    Fischer, M.3
  • 25
    • 84890346940 scopus 로고    scopus 로고
    • Japanese encephalitis vaccines
    • Plotkin SA, Orenstein WA, Offit PA, editors. 6th edition. Saunders Elsevier
    • Halstead SB, Jacobson J, Dubischar-Kastner K. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th edition. Saunders Elsevier; 2012. p. 312-51
    • (2012) Vaccines , pp. 312-351
    • Halstead, S.B.1    Jacobson, J.2    Dubischar-Kastner, K.3
  • 26
    • 79952672355 scopus 로고    scopus 로고
    • Japanese encephalitis in two children-United States, 2010
    • Centers for Disease Control and Prevention (CDC). Japanese encephalitis in two children-United States, 2010. MMWR Morb Mortal Wkly Rep 2011;60(9):276-8
    • (2011) MMWR Morb Mortal Wkly Rep , vol.60 , Issue.9 , pp. 276-278
  • 27
    • 80054894141 scopus 로고    scopus 로고
    • Japanese encephalitis in a Danish short-term traveler to Cambodia
    • Werlinrud AM, Christiansen CB, Koch A. Japanese encephalitis in a Danish short-term traveler to Cambodia. J Travel Med 2011; 18(6):411-13
    • (2011) J Travel Med , vol.18 , Issue.6 , pp. 411-413
    • Werlinrud, A.M.1    Christiansen, C.B.2    Koch, A.3
  • 28
    • 79959386976 scopus 로고    scopus 로고
    • A case of aseptic meningitis due to Japanese encephalitis virus in a traveller returning from the Philippines
    • Jeurissen A, Strauven T. A case of aseptic meningitis due to Japanese encephalitis virus in a traveller returning from the Philippines. Acta Neurol Belg 2011;111(2):143-5
    • (2011) Acta Neurol Belg , vol.111 , Issue.2 , pp. 143-145
    • Jeurissen, A.1    Strauven, T.2
  • 29
    • 84860365727 scopus 로고    scopus 로고
    • Epidemiology of Japanese encephalitis in South Korea, 2007-2010
    • Lee DW, Choe YJ, Kim JH, et al. Epidemiology of Japanese encephalitis in South Korea, 2007-2010. Int J Infect Dis 2012;16(6):e448-52
    • (2012) Int J Infect Dis , vol.16 , Issue.6 , pp. e448-e452
    • Lee, D.W.1    Choe, Y.J.2    Kim, J.H.3
  • 30
    • 84861672778 scopus 로고    scopus 로고
    • Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia
    • Tappe D, Nemecek A, Zipp F, et al. Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia. J Clin Virol 2012;54(3):282-5
    • (2012) J Clin Virol , vol.54 , Issue.3 , pp. 282-285
    • Tappe, D.1    Nemecek, A.2    Zipp, F.3
  • 31
    • 84883406592 scopus 로고    scopus 로고
    • A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013
    • Doti P, Castro P, Martinez MJ, et al. A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013. Euro Surveill 2013;18(35):20573
    • (2013) Euro Surveill , vol.18 , Issue.35 , pp. 20573
    • Doti, P.1    Castro, P.2    Martinez, M.J.3
  • 32
    • 84896729486 scopus 로고    scopus 로고
    • Japanese encephalitis in a French traveler to Nepal
    • Lagarde S, Lagier JC, Charrel R, et al. Japanese encephalitis in a French traveler to Nepal. J Neurovirol 2014;20(1):99-102
    • (2014) J Neurovirol , vol.20 , Issue.1 , pp. 99-102
    • Lagarde, S.1    Lagier, J.C.2    Charrel, R.3
  • 33
    • 84906718703 scopus 로고    scopus 로고
    • A case series of three US adults with Japanese encephalitis, 2010-2012
    • Hills SL, Stoltey J, Martinez D, et al. A case series of three US adults with Japanese encephalitis, 2010-2012. J Travel Med 2014;21(5):310-13
    • (2014) J Travel Med , vol.21 , Issue.5 , pp. 310-313
    • Hills, S.L.1    Stoltey, J.2    Martinez, D.3
  • 34
    • 84858441158 scopus 로고    scopus 로고
    • A case of Japanese encephalitis virus infection acquired during a trip in Thailand
    • Langevin S, Libman M, Drebot MA, et al. A case of Japanese encephalitis virus infection acquired during a trip in Thailand. J Travel Med 2012;19(2):127-9
    • (2012) J Travel Med , vol.19 , Issue.2 , pp. 127-129
    • Langevin, S.1    Libman, M.2    Drebot, M.A.3
  • 35
    • 84929512719 scopus 로고    scopus 로고
    • Japanese Encephalitis Vaccines: WHO position paper - February 2015
    • Japanese Encephalitis Vaccines: WHO position paper - February 2015. Wkly Epidemiol Rec 2015;90(9):69-87
    • (2015) Wkly Epidemiol Rec , vol.90 , Issue.9 , pp. 69-87
  • 37
    • 84887586601 scopus 로고    scopus 로고
    • Use of Japanese encephalitis vaccine in children: Recommendations of the advisory committee on immunization practices 2013
    • Centers for Disease Control and Prevention (CDC). Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices 2013. MMWR Morb Mortal Wkly Rep 2013;62(45):898-900
    • (2013) MMWR Morb Mortal Wkly Rep , vol.62 , Issue.45 , pp. 898-900
  • 38
    • 84939440886 scopus 로고    scopus 로고
    • [Last accessed 28 May]
    • Background paper on JE Vaccines-SAGE working group. Available from: www.who. int/immunization/sage/meetings/2014/october/1-JE-Vaccine-Background-Paper.pdf?ua=1 [Last accessed 28 May 2015]
    • (2015) Background Paper on JE Vaccines-SAGE Working Group
  • 39
    • 78649502687 scopus 로고    scopus 로고
    • IMOJEV((R)): A Yellow fever virus-based novel Japanese encephalitis vaccine
    • Appaiahgari MB, Vrati S. IMOJEV((R)): a Yellow fever virus-based novel Japanese encephalitis vaccine. Expert Rev Vaccines 2010;9(12):1371-84
    • (2010) Expert Rev Vaccines , vol.9 , Issue.12 , pp. 1371-1384
    • Appaiahgari, M.B.1    Vrati, S.2
  • 40
    • 0024264599 scopus 로고
    • Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; Adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use
    • Eckels KH, Yu YX, Dubois DR, et al. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 1988;6(6):513-18
    • (1988) Vaccine , vol.6 , Issue.6 , pp. 513-518
    • Eckels, K.H.1    Yu, Y.X.2    Dubois, D.R.3
  • 41
    • 0035860006 scopus 로고    scopus 로고
    • A purified inactivated Japanese encephalitis virus vaccine made in Vero cells
    • Srivastava AK, Putnak JR, Lee SH, et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 2001;19(31):4557-65
    • (2001) Vaccine , vol.19 , Issue.31 , pp. 4557-4565
    • Srivastava, A.K.1    Putnak, J.R.2    Lee, S.H.3
  • 43
    • 84993312701 scopus 로고    scopus 로고
    • Annex 1: Summary of Product Characteristics. [Last accessed 28 May]
    • European Medicines Agency. Ixiaro: EPAR - product information. Annex 1: Summary of Product Characteristics. Available from: www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000963/WC500037287.pdf [Last accessed 28 May 2015]
    • (2015) Ixiaro: EPAR - Product Information
  • 44
    • 84939441846 scopus 로고    scopus 로고
    • (Human) (Purified inactivated vaccine-adsorbed) JEEV. WHO [Last accessed 28 May 2015]
    • World Health Organization. Public assessment summary report update-Japanese encephalitis vaccine (Human) (Purified inactivated vaccine-adsorbed) JEEV. WHO 2014. Available from: http://www.who.int/immunization-standards/vaccine-quality/pq-266-je-1dose-biologicale-updated-vpsar.pdf?ua=1 [Last accessed 28 May 2015]
    • (2014) Public Assessment Summary Report Update-Japanese Encephalitis Vaccine
  • 45
    • 84939426648 scopus 로고    scopus 로고
    • Recommendations for inactivated Japanese encephalitis vaccine for human use
    • WHO Technical Report Series, No. 963, Annex 1. [Last accessed 28 May 2015]
    • World Health Organization. Recommendations for inactivated Japanese encephalitis vaccine for human use. In: WHO expert committee on biological standardization, fifty-eight report. WHO Technical Report Series, No. 963, Annex 1 2011. Available from: http://apps.who.int/medicinedocs/documents/s19541en/s19541en.pdf [Last accessed 28 May 2015]
    • (2011) WHO Expert Committee on Biological Standardization, Fifty-eight Report
  • 46
    • 26644464588 scopus 로고    scopus 로고
    • Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
    • Hombach J, Solomon T, Kurane I, et al. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. Vaccine 2005;23(45):5205-11
    • (2005) Vaccine , vol.23 , Issue.45 , pp. 5205-5211
    • Hombach, J.1    Solomon, T.2    Kurane, I.3
  • 47
    • 79960744859 scopus 로고    scopus 로고
    • Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO ((R))) induced neutralizing antibody titers
    • Van Gessel Y, Klade CS, Putnak R, et al. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO ((R))) induced neutralizing antibody titers. Vaccine 2011;29(35):5925-31
    • (2011) Vaccine , vol.29 , Issue.35 , pp. 5925-5931
    • Van Gessel, Y.1    Klade, C.S.2    Putnak, R.3
  • 48
    • 34047107914 scopus 로고    scopus 로고
    • A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis
    • Lyons A, Kanesa-thasan N, Kuschner RA, et al. A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Vaccine 2007;25(17):3445-53
    • (2007) Vaccine , vol.25 , Issue.17 , pp. 3445-3453
    • Lyons, A.1    Kanesa-Thasan, N.2    Kuschner, R.A.3
  • 49
    • 36549069631 scopus 로고    scopus 로고
    • Safety and immunogenicity of a Vero-cellderived, inactivated Japanese encephalitis vaccine: A non-inferiority, phase III, randomised controlled trial
    • Tauber E, Kollaritsch H, Korinek M, et al. Safety and immunogenicity of a Vero-cellderived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007; 370(9602):1847-53
    • (2007) Lancet , vol.370 , Issue.9602 , pp. 1847-1853
    • Tauber, E.1    Kollaritsch, H.2    Korinek, M.3
  • 50
    • 61549095001 scopus 로고    scopus 로고
    • Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
    • Schuller E, Klade CS, Wolfl G, et al. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study. Vaccine 2009;27(15):2188-93
    • (2009) Vaccine , vol.27 , Issue.15 , pp. 2188-2193
    • Schuller, E.1    Klade, C.S.2    Wolfl, G.3
  • 51
    • 67649365435 scopus 로고    scopus 로고
    • Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
    • Kaltenbock A, Dubischar-Kastner K, Eder G, et al. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. Vaccine 2009;27(33):4483-9
    • (2009) Vaccine , vol.27 , Issue.33 , pp. 4483-4489
    • Kaltenbock, A.1    Dubischar-Kastner, K.2    Eder, G.3
  • 53
    • 84939429399 scopus 로고    scopus 로고
    • Procedure No. EMEA/H/C/000963. [Last accessed 28 May 2015]
    • EMA. Assessment report for Ixiaro. Procedure No. EMEA/H/C/000963 2009. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Public-assessment-report/human/000963/WC500037286.pdf [Last accessed 28 May 2015]
    • (2009) Assessment Report for Ixiaro
    • EMA1
  • 54
    • 84859423409 scopus 로고    scopus 로고
    • Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
    • Woolpert T, Staples JE, Faix DJ, et al. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Vaccine 2012;30(20):3090-6
    • (2012) Vaccine , vol.30 , Issue.20 , pp. 3090-3096
    • Woolpert, T.1    Staples, J.E.2    Faix, D.J.3
  • 55
    • 84865475058 scopus 로고    scopus 로고
    • A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines
    • Erra EO, Askling HH, Rombo L, et al. A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines. Clin Infect Dis 2012;55(6):825-34
    • (2012) Clin Infect Dis , vol.55 , Issue.6 , pp. 825-834
    • Erra, E.O.1    Askling, H.H.2    Rombo, L.3
  • 56
    • 84871798025 scopus 로고    scopus 로고
    • Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes
    • Erra EO, Askling HH, Yoksan S, et al. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis 2013;56(2):267-70
    • (2013) Clin Infect Dis , vol.56 , Issue.2 , pp. 267-270
    • Erra, E.O.1    Askling, H.H.2    Yoksan, S.3
  • 57
    • 84908158054 scopus 로고    scopus 로고
    • Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study
    • Alberer M, Burchard G, Jelinek T, et al. Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study. Travel Med Infect Dis 2014;12(5):485-93
    • (2014) Travel Med Infect Dis , vol.12 , Issue.5 , pp. 485-493
    • Alberer, M.1    Burchard, G.2    Jelinek, T.3
  • 58
    • 84934833289 scopus 로고    scopus 로고
    • Short-term immunogenicity and safety of an accelerated pre-exposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: A Phase III, multicenter, observer-blind study
    • [Epub ahead of print]
    • Jelinek T, Burchard GD, Dieckmann S, et al. Short-term immunogenicity and safety of an accelerated pre-exposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: a Phase III, multicenter, observer-blind study. J Travel Med 2015. [Epub ahead of print]
    • (2015) J Travel Med
    • Jelinek, T.1    Burchard, G.D.2    Dieckmann, S.3
  • 59
    • 84939452257 scopus 로고    scopus 로고
    • Procedure No.: EMEA/H/C/000963/II/0039/G. [Last accessed 28 May 2015]
    • EMA. Assessment report. Ixiaro. Procedure No.: EMEA/H/C/000963/II/0039/G. 2013. Available from: www.ema.europa.eu/docs/en-GB/document-library/EPAR-Assessment-Report-Variation/human/000963/WC500142252.pdf [Last accessed 28 May 2015]
    • (2013) Assessment Report. Ixiaro
    • EMA1
  • 60
    • 78650416836 scopus 로고    scopus 로고
    • Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: Multicenter randomized controlled trial
    • Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, et al. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J 2010;29(12):1111-17
    • (2010) Pediatr Infect Dis J , vol.29 , Issue.12 , pp. 1111-1117
    • Chokephaibulkit, K.1    Sirivichayakul, C.2    Thisyakorn, U.3
  • 61
    • 84939459497 scopus 로고    scopus 로고
    • A Japanese encephalitis vaccine from India induces durable and cross-protective immunity against temporally and spatially wide-ranging global field strains
    • [Epub ahead of print]
    • Singh A, Mitra M, Sampath G, et al. A Japanese encephalitis vaccine from India induces durable and cross-protective immunity against temporally and spatially wide-ranging global field strains. J Infect Dis 2015. [Epub ahead of print]
    • (2015) J Infect Dis
    • Singh, A.1    Mitra, M.2    Sampath, G.3
  • 63
    • 77954959942 scopus 로고    scopus 로고
    • Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51
    • Dubischar-Kastner K, Eder S, Buerger V, et al. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51. Vaccine 2010;28(32):5197-202
    • (2010) Vaccine , vol.28 , Issue.32 , pp. 5197-5202
    • Dubischar-Kastner, K.1    Eder, S.2    Buerger, V.3
  • 64
    • 47849106825 scopus 로고    scopus 로고
    • Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
    • Schuller E, Jilma B, Voicu V, et al. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. Vaccine 2008;26(34):4382-6
    • (2008) Vaccine , vol.26 , Issue.34 , pp. 4382-4386
    • Schuller, E.1    Jilma, B.2    Voicu, V.3
  • 65
    • 79952248906 scopus 로고    scopus 로고
    • Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO(R), IC51
    • Eder S, Dubischar-Kastner K, Firbas C, et al. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO(R), IC51. Vaccine 2011;29(14):2607-12
    • (2011) Vaccine , vol.29 , Issue.14 , pp. 2607-2612
    • Eder, S.1    Dubischar-Kastner, K.2    Firbas, C.3
  • 66
    • 79958287508 scopus 로고    scopus 로고
    • Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: Advisory committee on immunization practices, 2011. MMWR Morb
    • Centers for Disease Control and Prevention (CDC). Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011. MMWR Morb. Mortal Wkly Rep 2011;60(20):661-3
    • (2011) Mortal Wkly Rep , vol.60 , Issue.20 , pp. 661-663
  • 67
    • 84891935899 scopus 로고    scopus 로고
    • Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study
    • Erra EO, Askling HH, Yoksan S, et al. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study. Vaccine 2013;32(1):119-23
    • (2013) Vaccine , vol.32 , Issue.1 , pp. 119-123
    • Erra, E.O.1    Askling, H.H.2    Yoksan, S.3
  • 69
    • 0014907356 scopus 로고
    • A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease
    • Kanamitsu M, Hashimoto N, Urasawa S, et al. A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease. Biken J 1970;13(4):313-28
    • (1970) Biken J , vol.13 , Issue.4 , pp. 313-328
    • Kanamitsu, M.1    Hashimoto, N.2    Urasawa, S.3
  • 70
    • 0344758398 scopus 로고    scopus 로고
    • Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants
    • Sohn YM, Park MS, Rho HO, et al. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine 1999;17(18): 2259-64
    • (1999) Vaccine , vol.17 , Issue.18 , pp. 2259-2264
    • Sohn, Y.M.1    Park, M.S.2    Rho, H.O.3
  • 71
    • 84903733790 scopus 로고    scopus 로고
    • Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults
    • Takeshita N, Lim CK, Mizuno Y, et al. Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults. J Infect Chemother 2014; 20(4):238-42
    • (2014) J Infect Chemother , vol.20 , Issue.4 , pp. 238-242
    • Takeshita, N.1    Lim, C.K.2    Mizuno, Y.3
  • 74
    • 84954358400 scopus 로고    scopus 로고
    • Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
    • Schuller E, Klade CS, Heinz FX, et al. Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51. Vaccine 2008; 26(48):6151-6
    • (2008) Vaccine , vol.26 , Issue.48 , pp. 6151-6156
    • Schuller, E.1    Klade, C.S.2    Heinz, F.X.3
  • 76
    • 67649393351 scopus 로고    scopus 로고
    • Vaccination in the elderly: An immunological perspective
    • Chen WH, Kozlovsky BF, Effros RB, et al. Vaccination in the elderly: an immunological perspective. Trends Immunol 2009;30(7):351-9
    • (2009) Trends Immunol , vol.30 , Issue.7 , pp. 351-359
    • Chen, W.H.1    Kozlovsky, B.F.2    Effros, R.B.3
  • 77
    • 71349087878 scopus 로고    scopus 로고
    • Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
    • Kaltenbock A, Dubischar-Kastner K, Schuller E, et al. Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age. Vaccine 2010;28(3):834-9
    • (2010) Vaccine , vol.28 , Issue.3 , pp. 834-839
    • Kaltenbock, A.1    Dubischar-Kastner, K.2    Schuller, E.3
  • 78
    • 84939421407 scopus 로고    scopus 로고
    • STN 125280/125. (Clinical reviewer: Fink, DL.). [Last accessed 28 May 2015]
    • FDA. Clinical review - Ixiaro. STN 125280/125. (Clinical reviewer: Fink, DL.) 2013. Available from: www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM354012.pdf [Last accessed 28 May 2015]
    • (2013) Clinical Review - Ixiaro
    • FDA1
  • 79
    • 84939418860 scopus 로고    scopus 로고
    • 24-months antibody persistence in children with and without a booster dose of an inactivated Japanese encephalitis vaccine, JE-VC, IC51
    • 5-8 June, Bergen, Norway
    • Dubischar-Kastner K, Kadlecek V, Bézay N, et al. 24-Months antibody persistence in children with and without a booster dose of an inactivated Japanese encephalitis vaccine, JE-VC, IC51. Presented at The 5th Northern European Conference on Travel Medicine. 5-8 June 2014, Bergen, Norway
    • (2014) Presented at the 5th Northern European Conference on Travel Medicine
    • Dubischar-Kastner, K.1    Kadlecek, V.2    Bézay, N.3
  • 80
    • 84939452825 scopus 로고    scopus 로고
    • Safety and immunogenicity data for inactivated Japanese encephalitis vaccine (JEVC), IC51, in children from je non-endemic countries
    • 5-8 June, Bergen, Norway
    • Dubischar-Kastner K, Ayad A, Cramer J, et al. Safety and immunogenicity data for inactivated Japanese encephalitis vaccine (JEVC), IC51, in children from je non-endemic countries. Presented at The 5th Northern European Conference on Travel Medicine. 5-8 June 2014, Bergen, Norway
    • (2014) Presented at the 5th Northern European Conference on Travel Medicine
    • Dubischar-Kastner, K.1    Ayad, A.2    Cramer, J.3
  • 81
    • 84881054008 scopus 로고    scopus 로고
    • Global advisory committee on vaccine safety,12-13 June 2013
    • Global advisory committee on vaccine safety,12-13 June 2013. Wkly Epidemiol Rec 2013;88(29):301-12
    • (2013) Wkly Epidemiol Rec , vol.88 , Issue.29 , pp. 301-312
  • 82
    • 82455192358 scopus 로고    scopus 로고
    • Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R))
    • Schuller E, Klingler A, Dubischar-Kastner K, et al. Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R)). Vaccine 2011;29(47):8669-76
    • (2011) Vaccine , vol.29 , Issue.47 , pp. 8669-8676
    • Schuller, E.1    Klingler, A.2    Dubischar-Kastner, K.3
  • 84
    • 84921281365 scopus 로고    scopus 로고
    • Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012
    • Rabe IB, Miller ER, Fischer M, et al. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012. Vaccine 2015;33(5): 708-12
    • (2015) Vaccine , vol.33 , Issue.5 , pp. 708-712
    • Rabe, I.B.1    Miller, E.R.2    Fischer, M.3
  • 85
    • 77956399155 scopus 로고    scopus 로고
    • Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up
    • Dubischar-Kastner K, Kaltenboeck A, Klingler A, et al. Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up. Vaccine 2010; 28(39):6463-9
    • (2010) Vaccine , vol.28 , Issue.39 , pp. 6463-6469
    • Dubischar-Kastner, K.1    Kaltenboeck, A.2    Klingler, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.